Project Screen by Prenetics is an initiative developed by Prenetics, a healthcare company with headquarters in London and Hong Kong.
Read MoreDr. Rachel Liebmann
Group Medical Director, The Doctor’s Laboratory and Vice President of the Royal College of Pathologists
Dr. Mark Atkin
Consultant Virologist, The Doctor’s Laboratory
Dr. Senthil Sundaram, MD
Chief Clinical Officer at Prenetics; Leads clinical development of molecular genetic testing
Dr. Lawrence Tzang CH, BSc, PhD, Reg MLT
Chief Scientific Officer & Laboratory Director of Prenetics COVID-19 Screening Facility
Prof. Alan McNally, BSC, PhD
Director of Institute of Microbiology and Infection, University of Birmingham
Prof. Willem Van Schaik, MSc, PhD
Institute of Microbiology and infection, University of Birmingham
Prof. Michael M Yang, PhD
Head and Chair Professor, Department of Biomedical Sciences at City University of Hong Kong
Dr. Richard H. Kaszynski, M.A, M.D,PhD
Co-Founder: Stanford Solutions, a healthcare innovation group founded out of Standard University School of Medicine. Executive Director, Shinwakai Medical Group, Tokyo, Japan